VIROREPLICATIVE GENE THERAPY TARGETED TO PROSTATE CANCER

$495,938FY2008Department of the ArmyDOD

University Of California, Los Angeles

Investigators

View source on USAspending →

VIROREPLICATIVE GENE THERAPY TARGETED TO PROSTATE CANCER · GrantIndex